Literature DB >> 12140774

No association between dopamine D4 receptor gene exon III and -521C/T polymorphism and novelty seeking.

A Strobel, K P Lesch, K Hohenberger, S Jatzke, H O Gutzeit, K Anacker, B Brocke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140774     DOI: 10.1038/sj.mp.4001027

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  5 in total

1.  Attention-Deficit Hyperactivity Disorder in the post-genomic era.

Authors:  Philip Asherson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

2.  The polymorphic nature of the human dopamine D4 receptor gene: a comparative analysis of known variants and a novel 27 bp deletion in the promoter region.

Authors:  E Szantai; R Szmola; M Sasvari-Szekely; A Guttman; Z Ronai
Journal:  BMC Genet       Date:  2005-06-28       Impact factor: 2.797

3.  No direct effect of the -521 C/T polymorphism in the human dopamine D4 receptor gene promoter on transcriptional activity.

Authors:  Eva Kereszturi; Orsolya Kiraly; Csaba Barta; Noemi Molnar; Maria Sasvari-Szekely; Zsolt Csapo
Journal:  BMC Mol Biol       Date:  2006-05-24       Impact factor: 2.946

4.  DRD4 Exon 3 Gene Polymorphisms in Patients Diagnosed with Polysubstance Use Disorder and Co-Occurrence of a Depressive Episode.

Authors:  Krzysztof Chmielowiec; Jolanta Chmielowiec; Jolanta Masiak; Małgorzata Czekaj; Piotr Krawczyk; Ewelina Soroka; Małgorzata Śmiarowska; Wojciech Musiał; Tomasz Pawłowski; Anna Grzywacz
Journal:  Genes (Basel)       Date:  2021-11-20       Impact factor: 4.096

5.  Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers.

Authors:  Erik G Jönsson; Jessica Bah; Jonas Melke; Rami Abou Jamra; Johannes Schumacher; Lars Westberg; Roland Ivo; Sven Cichon; Peter Propping; Markus M Nöthen; Elias Eriksson; Göran C Sedvall
Journal:  BMC Psychiatry       Date:  2004-03-04       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.